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2007 Cancer Care Annual Report

Focus on Osteogenic Sarcoma



Now, slightly more than 50 years into
the battle of childhood cancer with the
use of chemotherapy, the cure rates
have never been higher. But they are
not high enough. Only through ongoing
and future research can we achieve
our ultimate goals of 100 percent
cure and perhaps even prevention in
the years to come. It was nearly 20
years ago when it was first shown in
clinical trials for osteosarcoma that
the use of chemotherapy in addition
to surgery increased the cure from
17 to 66 percent. Children’s Mercy
Hospitals and Clinics is an active
participant in these efforts and as such
makes available to our patients the
newest approaches to therapy being
investigated. This is possible through
the availability of a number of clinical
trials available at Children’s Mercy, one
of the larger Childhood Cancer Centers
in the Children’s Oncology Group, the
National Cancer Institute’s cooperative
organization for childhood cancer
research.

This year’s Annual Report for the
Children’s Mercy Cancer Center focuses
upon our most common bone tumor
in children, Osteogenic Sarcoma aka
Osteosarcoma. This cancer is seen
most often in adolescents but may be
seen in children as young as 5 years
or less. From the following discussions
and the age and developmental range of
the children affected by this cancer, it is
clear that a multidisciplinary and multispecialty team is critical to the ultimate
successful cure and rehabilitation
of the child. Just as critical is an
experienced team, trained and focused
in the nuances of the developing child
with cancer of the bone. We are proud
to have such services available at
Children’s Mercy Hospitals and Clinics,
and invite you to read further about
them in this year’s report. We hope this
provides you with a clear picture of all
that can be gathered together here in
the fight against this childhood cancer
but also we invite you to contact us with
any and all questions that you might
have.
Our best wishes to you and the families
of our patients,

Alan S Gamis, MD, MPH
Chief, Section of Oncology
Division of Hematology/Oncology &
Bone Marrow Transplantation



Dear Friends,
I can’t imagine what a parent must feel
when he or she hears a doctor say, “Your
child has cancer.” Fortunately, most of
us as parents never have to deal with
hearing those words. But for those
who do, the oncologists and staff at
Children’s Mercy Hospitals and Clinics
are able to offer a complete arsenal of
ways to treat these diseases, as well
as the emotional support and familycentered care that provides support not
only for the patient, but for the entire
family as well.
Our Cancer Care Annual Report tells
the story of how our staff does just
that. This year’s report includes a
special focus on our work in patients
with osteogenic sarcoma, although we
provide the same depth and breadth
of care to all of our patients with a
variety of cancer diagnoses. I hope you
will take a few moments to read this
report and learn more about how our
nationally-recognized pediatric oncology
program provides exceptional care for
these children and families.

Our program not only cares for the
children with cancer of today, but we
are actively engaged in a wide variety
of research programs to improve the
treatments available to the children
with cancer of tomorrow, and hopefully
someday to find a cure for this disease.
We also are active in educating our
future pediatricians on the best ways to
provide medical care for children with
cancer.
There have been tremendous strides
made in recent years in improving
the treatments and the outcomes for
children with cancer, as you will read in
the following pages. And everyone in the
Children’s Mercy oncology program is
committed to continuing that progress in
the years to come.

Sincerely,

Randall L. O’Donnell, PhD
President and Chief Executive Officer
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13 Osteogenic Sarcoma | 18 From Patient to “Paging Dr. Myers” | 20 Osteosarcoma - A Multi-Disciplinary Effort of Care | 26 Tyler’s Triumph



The Division of Hematology/Oncology

Close to 2,000 children are seen each year by the physicians and other health care providers
within the Division of Hematology/Oncology. The vast majority of these are patients seen for
treatment or follow-up of their cancer, but the Division’s Sickle Cell and Hemophilia programs
each have nearly 300 active patients that are seen. Patients with other hematological issues or
diagnoses are also routinely seen by physicians.
The comprehensive services of the
Division allow children and families the
well-rounded care that they need during
challenging times. As patients progress
from diagnosis, to treatment, to followup care, specific needs are continually
addressed by different members of the
team.
During the year, ten physicians and
three fellows provided care to the
patients seen in the out-patient clinic
and in-patient floor. During 2007 1,191
admissions occurred on the inpatient
floor, and there were 8,816 clinic visits.
Each physician actively participates
in the many clinical trials that are
available to children who are treated at
Children’s Mercy. Through professional
organizations and research links such as
the Children’s Oncology Group, Centers
for Disease Control, and the National
Institutes of Health, physicians provide
cutting edge therapy to all patients.
Advance practice nurses, each
working alongside a specific physician,
coordinate patient care to ensure that all
aspects of their unique case is carried
out efficiently and effectively. Whether
it is scheduling appointments outside of
the Division, sifting through insurance
issues, ensuring treatment protocols are



followed, or providing hands-on clinical
care, the advanced practice nurse is a
vital team member for the Hematology/
Oncology family.
The nursing team that cares for patients
in the clinic and on the inpatient floor
number over 100. Nurses provide
direct care to patients, administer
chemotherapy and other treatment
drugs, provide administrative and clinical
record-keeping, and are a comforting
presence during an oftentimes stressful
period. Many of the nurses within
the Division have received advanced
certification in their specialty. All nurses
receive continuous specialized training
during their tenure.
Administrative and research support
complement the work that the
clinical providers give. Schedulers,
administrative assistants, research
coordinators, and data managers
work behind the scenes, but provide
integral services to both patients and
families. Schedulers assist in keeping
patients on track with appointments
with as little life disruption as possible.
Administrative assistants make sure that
information is exchanged appropriately
among caregivers inside and outside
the hospital. Research and data

management staff coordinate the more
than 100 clinical trials that are offered
throughout the Division.
Care and commitment for the children
treated does not stop at the clinic and
inpatient doors. Support throughout
the hospital allows each patient
access to the other specialists who
can significantly impact their care.
Whether it is a surgeon, endocrinologist,
neurologist, or pathologist, all
specialists are available to assist
in the management of patients as
needed. Nutritionists follow patients
carefully along the treatment course.
Psychologists, social workers, chaplains,
music therapists and child life
specialists work with the whole child
and the whole family to create positive
experiences and outcomes. Volunteers
offer comfort and care to children, family
and staff throughout the hospital.
We hope that this report highlights the
work of the Division of Hematology/
Oncology. We especially hope that it
offers a picture of the dedicated team
that is required to bring the best care to
our patients. At Children’s Mercy, we are
lucky to have one of the best there is!

Division Chief - Gerald Woods, MD
Division Manager - Sue Stamm, RN, MSN, CPNP
The Section of Oncology
Section Chief - Alan Gamis, MD
o Oncology Service: Director - Alan Gamis, MD
o Bone Marrow Transplant Service: Director - Jignesh Dalal, MD
The Section of Hematology
Section Chief - Gerald Woods, MD
o Sickle Cell Disease Service: Director - Gerald Woods, MD
o Regional Hemophilia Center: Director - Brian Wicklund, MD



Jonathan (seated) is all smiles as he and his family celebrate at his going home party.



A

He sang. He danced. A writer and an
athlete, Jonathan Stepp a Shawnee
Mission East high school student did it
all. As a cross-country runner, Jonathan
noticed that his leg didn’t heal after a
long run. After testing and the removal
of a tumor, the doctor talked to his Dad,
a local neurosurgeon. Jonathan was
diagnosed with osteosarcoma. His initial
shock was soon replaced by peace from
his strong faith as he waited a week to
tell his friends.
Losing 12 pounds in his first week of
chemotherapy he continued with 17
more rounds. In addition to running,
Jonathan had played tennis, basketball,
soccer and wanted to be a football
punter, but the crutches from his
knee replacement surgery were one
more reminder that he was benched.
Instead he worked hard to keep up with
his studies as he utilized the school
district’s Home Bound program for the
next four to five months.

Jonathan stepp

Stepp In the Right Direction

Jonathan’s hard work paid off as he
learned that he was cancer-free shortly
after his 17th birthday. What a GREAT
birthday present.
Jonathan has many heroes. As an avid
athlete himself, Jonathan was moved
by fellow athlete Lance Armstrong in
his race to overcome cancer. He is also
inspired by J.K. Rowling, the creator/
author of the Harry Potter books as
Jonathan is working on his own book
about his experiences with cancer. His
interest in medicine was also sparked
by his own encounters and he plans
to volunteer as a Care Assistant at
Children’s Mercy Hospital. This will give
him an opportunity to see things from
the other side of the bed. With restored
hope, Jonathan still holds on to his
dream of becoming an ESPN anchor,
living and loving life cancer-free.



cancer registry

Cancer registration and subsequent follow-up of patients is a standard practice at Children’s
Mercy Hospitals and Clinics (CMH). The Cancer Registry collects data in relation to cancer
cases and benign tumors that are diagnosed and/or treated at Children’s Mercy Hospital. The
data collection requirements of the Commission on Cancer (CoC) of the American College of
Surgeons as well as the Missouri Cancer Registry are maintained. This information is then
reported to the Missouri Central Cancer Registry and the National Cancer Data Base. The
Children’s Mercy Hospital Cancer Registry operates under the guidance of the Cancer Care
Committee, which is comprised of numerous staff physicians and clinical staff.
Cancer Registry information is vital for research in the prevention and treatment of cancer.
Below are some questions and answers that may be beneficial in understanding the registry
procedures.
PARENTS AND PATIENTS MAY LIKE TO KNOW:
WHY is there a cancer registry?
• All health care facilities are required by federal and state law to provide data for all patients diagnosed and/or
treated. CMH data is sent to the Missouri Cancer Registry located in Columbia, MO. The state registry is under
the direction of the Missouri Department of Health and Senior Services and contracts with the University of
Missouri for operation. Data is also reported to the National Cancer Data Base.
• Data collected by Registrars allows state and national cancer registries to analyze and determine the impact of
cancer for those residing in the state.
WHAT kind of information is reported?
• Patient demographics including age, gender, race, Hispanic origin, place of birth and residence.
• The location of cancer in the body and histological type of cancer.
• The extent of disease invasion within the body.
• Treatment including surgery, radiation, chemotherapy, hormone or immunotherapy.
• Current status of patients (cancer free or recurrence).
WHY am I getting yearly follow-up contacts?
• By following our previous patients we can evaluate the best treatment methods and allow for surveillance of
patient outcomes. Successful follow-up must be maintained to provide optimal patient care.
WHAT about patient confidentiality?
• The Registry at Children’s Mercy follows the same strict patient confidentiality guidelines as the State Cancer
Registry. According to HIPAA privacy regulations, the State Cancer Registry is a public health authority
authorized by law to collect and receive information for the purpose of preventing and controlling disease,
injury or disability. A covered entity such as a hospital or physician’s office can disclose information to the State
Cancer Registry without specific individual informed consent. However, the identities of patients or specific
facilities / physicians are not released by the State Cancer Registry without written consent from the individual
or facility/physician.



2007 CMH CANCER REGISTRY
HIGHLIGHTS:
During 2007, 168 newly diagnosed
patients were added to the registry.
The most frequent diagnoses during
2007 were tumors of the central
nervous system. A snapshot of the top
five diagnoses in 2007 include central
nervous system tumors, leukemia,
lymphoma, neuroblastoma, and
hepatoblastoma. See Table I for overall
percent rankings.
The median age of patients diagnosed
during 2007 was 6 years. The
breakdown by age of diagnosis in 2007
are as follows: 20 patients less than 1
year of age, 56 patients between 1 and
4 years, 40 patients between 5 and 9
years, 26 patients between 10 and 14
years, and 26 patients diagnosed at 15
years of age or greater. The female/
male ratio was 90/78 = 1.15 for 2007.
During 2007, patients came to CMH for
cancer/tumor care from 36 different
counties and 3 different states. 51
percent of the patients were from
Missouri counties, 47 percent from
Kansas counties and two percent from
other counties. All are reported to the
Missouri Cancer Registry who correlates
data with the Kansas Cancer Registry for
Kansas residents.
There were 19 cancer-related deaths
during 2007, with five of these patients
diagnosed during the same year.
The leading mortality diagnosis was
leukemia (6), followed by neuroblastoma
(5) and brain tumors (4).

CANCER REGISTRY
2007 FREQUENCY OF DIAGNOSIS
TABLE I.
		
Diagnosis
Totals
Central Nervous System
44
Astrocytoma	13	
Glioma
8
Ependymoma	3	
Medulloblastoma	2	
PNET	2	
Atypical Teratoid Rhabdoid	1	
N.G. Germ Cell	1	
Astroblastoma	1	
Ganglioglioma,anaplastic	1	
Benign/Borderline	12	
Leukemia
37
ALL
29
AML
6
Other	2	
Lymphoma
12
Non-Hodgkins
8
Hodgkins	4	
Neuroblastoma
12
Hepatoblastoma
6
Osteosarcoma
5
Wilms Tumor
4
Rhabdomyosarcoma
2
Ewings Sarcoma (EFT)
4
Other
15
Carcinomas
7
Germ Cell Tumors	3	
Malig. Sertoli Cell Tumor	1	
Malig. Pleomorphic Sarcoma	1	
Melanoma	1	
Myelodysplastic Syndrome	1	
Retinoblastoma	1	
Misc. Reportable Conditions
27
Totals
168

Percentage
26%

22%

7%

7%
4%
3%
2%
1%
2%
10%

16%
100%



Abbas Emami, MD

Honoring a Children’s Mercy Hero

In March of 1995, Dr. Abbas Emami
began working at Children’s Mercy
Hospitals and Clinics. While many
things led him on this journey, the most
important was that he loved children.

patients. Chances for a cure for a patient
diagnosed with osteosarcoma in the
1960’s and 1970’s were between 30
and 40 percent. Now, the survival rate is
up to 70 or 80 percent.

His initial interest in pediatric cancer
medicine began in his residency
at a children’s hospital in Detroit.
A challenging fellowship provided
him opportunities that added to his
character. It was there that Dr. Emami
says “He learned to manage his
emotions.” He also wanted to promote
trust. Through his experiences, he
learned how to connect with both his
patients and their families, while dealing
with his own emotions. According to
Dr. Emami “these are important skills
to have when working with cancer
patients.”

Cancer treatment demands a dedicated
team of individuals to manage the
treatment plan and provide psychosocial
support. With many years of following his
patients closely, Dr. Emami reflected on
his indebtedness to many outstanding
colleagues and friends who provided
support.

During his career, Dr. Emami witnessed
many advancements take place. Instead
of treating osteosarcoma with surgery
alone which included amputation,
research has shown a critical role for
systemic chemotherapy in increasing
the cure rate and facilitating limb
salvage reconstruction surgery in most
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When asked how cancer impacted him
personally, he replied, “People of all
ages have hopes, plans and dreams.
Cancer is the major event that puts a
stop to that as people work through
treatment.” Dr. Emami saw first-hand
how cancer affected patients and their
families. Life seemed to be put on
hold for everyone as they dealt with
the emotional and physical trials of
treatment.
Recalling an event that held a lasting
impression, Dr. Emami spoke of a
16-year-old girl who had run into

complications and found herself in the
ICU on a ventilator. Her future looked
bleak. Dr. Emami talked to her parents
about difficult decisions that they would
have to consider, but advised them
to wait. The next morning, his patient
improved dramatically. One week later,
she was off the respirator and went
on to complete her chemotherapy
treatments. After leaving the hospital, he
later learned that his patient had gone
on to graduate from high school and
enrolled in college.
Retiring late in 2007, Dr. Emami
reflected on the most rewarding part
of his job. In addition to receiving
graduation, wedding and family photos,
many of his patients would stop him in
the mall or at a restaurant, exclaiming
“Do you remember me?” He listened
as they would fill him in on their second
chance at life. As they thanked him, he
smiled looking past the once sick child
to a healthy lively adult.

Dr. Emami is proud to have touched the lives of so many at Children’s Mercy Hospital.
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Osteogenic Sarcoma
It often begins with some
everyday bump or fall
any child has. Jana was
playing during recess and
her best friend Malinda
ran into her knocking
Jana onto the ground.
She had scraped her
elbow and her arm stung.
A few days later, her arm
still hurt and she went to
see her pediatrician who
ordered an x-ray. The
good news: there were no
broken bones. The bad
news: there was a mass of
some sort in her shoulder.

For Jeremy, a long distance runner looking forward
to graduating and going onto college the pain in his
leg was nothing too unusual but it had not gone away
after several weeks. The ibuprofen that usually worked
was no longer keeping the pain under control and
now it was starting to bother him even when he wasn’t
running. As a small bump began to appear on the side
of his leg, he shared this information with his parents.
An X-ray of his leg revealed a mass that appeared to
be growing out from his bone.

Troy loves basketball. He especially loves playing basketball. He was
always better than the other kids and now something even better was
happening. He was growing…taller! Puberty had started and so had his
growth spurt. The pain in his leg, mostly felt at night had been occurring
for several weeks. He didn’t remember falling or hitting anything. There
was this time two years ago when he fell out of a golf cart but other than
that, nothing came to mind. He had told his mom and she reassured him
that this was “growing pains”. After a few weeks, she took him to the
family physician who also felt that this was most likely “growing pains”.
Still this pain didn’t get any better and mom took him back to the doctor
who ordered an x-ray that showed a lesion in his leg.
These three histories, no different than
what occurs everyday, converge at this
point. An abnormal x-ray leads to a work
up that concludes with a diagnosis of
Osteogenic Sarcoma, a rare but most
common primary bone tumor in children
and adolescence.
Perhaps best known in the United States
as the cancer Ted Kennedy’s son (Ted
Kennedy Jr.) had when he was 12 years
old (he just celebrated his 47th birthday)
or in Canada where Terry Fox ran

across his country (with just one leg),
the treatment options have expanded
greatly from amputation.
Today treating Osteogenic Sarcoma
involves a comprehensive multi
disciplinary team of physicians,
technicians, therapists, nurses, and
social workers, dealing with medical,
surgical, emotional, school, physical,
cosmetic, and functional issues and that
is true without even considering possible
setbacks.

This year’s annual report is focusing
on Osteogenic Sarcoma in honor of
one of our colleagues, Dr. Abbas Emani
who dedicated many years of his
career treating young people with this
particular cancer.
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Osteogenic Sarcoma (OS) is a malignant
tumor that originates from the spindle
cell that produce osteoid—the building
block of bones. Malignant bone tumors
are rare. They make up approximately
six percent of all childhood cancers. The
annual incidence in children under age
twenty is 8.7 per million. OS make up
56 percent of bone tumors (compared
to Ewing Sarcoma 34 percent) and
is the most common. In the United
States, approximately 400 children are
diagnosed each year with Osteogenic
Sarcoma. Here at Children’s Mercy
Hospital we have seen 46 children with
osteogenic sarcoma in the past 10
years.
While as with most cancers, we don’t
fully understand what causes it, there
are some things that are known:
• The peak incidence of bone
cancer is 15 – 19 years, which
is coincident with the adolescent
growth spurt.
• It is very unusual to diagnose OS
in someone under age 10.
• The patient is usually taller than
average.
• The most common sites are at
the metaphyses (the most rapidly
growing part of bones) of the
distal femur and proximal tibia (60
percent involve this knee area)
and the proximal humerus.
• There is a genetic factor in that
children who have had bilateral
retinoblastoma (a cancer of the
eye) are at risk of developing OS
regardless of any exposure to
radiation or other therapies.
• Chromosome abnormalities such
as the Retinoblastoma recessive
oncogene (Rb) and a second
recessive oncogene (p53) have
been found in up to 25 percent of
patients.
14
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There is also a relationship
in families with Li-Fraumeni
syndrome in which affected
family members have a variety of
cancers including OS.
The most common environmental
factor related to developing OS is
radiation.
About three percent of OS
develop in bones that have been
previously irradiated for other
reasons.
Alkylating agents which are used
to treat other cancers may lead to
the development of OS.
Other bone diseases have a
slightly higher incidence of OS
compared to the general public.

The average length of symptoms is
about three months. The most common
complaint is pain (90 percent) but only
about half have any local swelling at
the site. Again, about half will have a
decreased range of motion and while
not common, about 10 percent will
present with a pathologic fracture.
It is imperative that the work-up is done
with the collaboration of an orthopaedic
surgeon who is familiar and comfortable
with treating malignant bone tumors in
children.
Whether the patient is initially referred to
a pediatric oncologist or the orthopaedic
surgeon is not particularly important
as it is essential that both have the
opportunity to evaluate, discuss, and
coordinate the various diagnostic and
therapeutic steps and options.
Initially, more specific radiologic
scanning is required to get a more
precise definition of the tumor. At
the time of the initial referral the
diagnosis of OS is still only a serious

concern. It will take a biopsy of the
tumor to confirm. A MRI is usually
obtained. Again, it is essential that the
surgeon who does this biopsy also be
the surgeon who addresses the more
formal and definitive surgical treatment
options. Once the biopsy is obtained,
one must then wait for the pathologist to
review and record there findings. Unlike
other biopsies, these results often take
a little longer due to the fact that these
are bone tumors and it takes longer to
process compared to other tissues.
Once the diagnosis is confirmed it is
now necessary to stage the tumor.
Most tumors are localized to the one
area of concern, but OS can have
“skip lesions”. These are areas of
tumor involvement that are outside
the reactive rim but within the same
bone (regional intraosseous spread) or
across a neighboring joint (transarticular
metastases). Systemic metastases have
a predilection for the lungs. Spread to
other bones is the second most common
site for spread and usually does not
occur until after spread to the lungs has
occurred.
The treatment for OS involves mostly
two areas of cancer treatment:
chemotherapy and surgery. Radiation
that is useful in many other types of
malignancies and is effective in the
treatment of Ewing Sarcoma has a very
limited role in the treatment of OS.
Historically, it was found that if you cut
the tumor out you could successfully
treat many patients with OS. This
led to amputation being the standard
surgical approach because of the
recurrence of tumor at the primary site
and subsequent metastases. In order to
make a proper fitting prosthetic, several
weeks were required. Amputation is
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not an easy thing to handle at anytime
in one’s life but is even more so in a
young adult. In order to decrease the
time from losing ones natural limb and
to begin the rehabilitation with the new
prosthetic limb, chemotherapy was
initiated.
Not too surprisingly, in many cases
the chemotherapy had an affect on
the tumor. Often there was notable
decrease in the swelling and a decrease
in the pain. These changes were seen
on scans as well. Most importantly
when the tumor was evaluated after
receiving this chemotherapy often some
or most of the tumor was found to be
necrotic or dead when the pathologist
examined it.
This tumor kill was looked at and it was
found to be very prognostic. Those with
a high amount of tumor kill were found
to have a better prognosis than those
with a low amount of tumor kill.
As our ability to fabricate prosthetic
limbs has dramatically improved in
speed of production, cosmetic and
function current treatments still
incorporate this upfront chemotherapy
prior to definitive surgical intervention
that now takes place approximately
twelve weeks after commencing
chemotherapy.
In addition, the surgical options have
also progressed both in techniques
and materials. While prosthetic limbs
often provide a functioning limb, it still
is not always as good as the limb one
was born with. While prosthetic limbs
can now be custom painted to resemble
one’s natural skin color, there is still
no substitute for one’s natural limb.
Orthopaedic surgeons began looking
at ways to salvage the limb in question.

Could improved surgical techniques
eliminate the concern of a local
recurrence at the original site of tumor
involvement and could limb salvage
techniques and materials allow one to
retain one’s natural limb? Over time,
both the techniques and materials have
advanced. What for many of us was
fiction not so long ago in characters like
Steve Austin the Six Million Dollar Man,
are a reality for many of our patients.
For those patients with a localized tumor
that has been removed and found to
have a good tumor kill (>90 percent)
long-term survival is seen in 60-70
percent of patients. This increases
to over 80 percent in those with >98
percent tumor kill. Unfortunately,
these numbers significantly decrease
with lower levels of tumor kill. With
metastases, as suspected, the success
rate is even lower.
Whether an amputation or limb salvage
is performed, in addition to having to
deal with all of the normal side effects of
chemotherapy the need for rehabilitation
and physical therapy is immense.
Staying positive, active, motivated, when
stays in the hospital are frequent and
often prolonged is not easy.
Staying up on school work with frequent
and prolonged absences from school
and friends is not easy. Having a limb
that doesn’t function or look the same
can be overwhelming.

tumor involvement of bones. Often
many different options for pain control
come into play at sometime in the
course of treatment. These can include
simple oral medications, patches,
intravenous medications, creams,
massages, and indwelling pain pumps.
Finally, there is the very real fear about
resistant, recurrent, and relapsed
disease. These words and the
discussions that follow are never easy
for the patients, families or those taking
care of them. Once again, the path
taken is different and unique for each
patient. Whether it is investigational
therapy or supportive care it continues
to be a multi-disciplinary approach that
we offer.
Currently, Children’s Mercy Hospital,
through our participation with Children’s
Oncology Group, treats patients through
several different treatment protocols,
some of which are international in
collaboration. All of these treatments
require the cooperation of many
specialties.
I invite you to learn a bit more about the
multitude of services that we provide to
patients and families. Years ago, I was
asked what made the area of pediatric
oncology unique. The “Team Effort” is
never more demonstrated than in the
treatment of OS. Come meet the rest of
the team.

Usually most cancers are not associated
with pain. Pain is usually associated
with infection or inflammation. With OS,
pain is common at presentation and
unfortunately may be a very real concern
during treatment when it is associated
with the surgical procedure, or more
troublesome, when it is associated with
17

Dr. Myers now enjoys helping Children’s Mercy patients every day.
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Angela Myers, MD

from patient to “paging Dr. Myers”

From patient to doctor, Dr. Angela Myers
beat cancer and now fights to keep
others well.
Angie was only 16 years old when she
began favoring her leg due to chronic
knee pain. Angela’s parents took her to
an orthopaedic surgeon who suggested
more tests. On the way home from the
doctor’s office, her mother’s silence left
her feeling uneasy.
Angie spent the next day having those
tests to help confirm the suspected
diagnosis The following morning, her
parents came into her room and sat
down on the bed with crutches in hand,
and told her “You have bone cancer.”
Overwhelmed, Angela’s mind raced back
to third grade when a boy in her class
had died of leukemia.
After receiving her first round of chemotherapy at the Mayo Clinic, her doctor
suggested that she see Dr. Maxine
Hetherington a Hematology/Oncology
physician at Children’s Mercy Hospitals
and Clinics. Angie began her journey
with chemotherapy and surgery to
receive a knee replacement. Amazingly,
Angie was able to keep up with her

studies and graduate with her high
school class.
Determined to be a doctor herself, she
was thrilled to be accepted into the
University of Missouri-Kansas City’s
medical program in 1995. Although she
had a few surgeries for metastatic bone
cancer during her college years, she was
able to graduate and complete pediatric
residency at Children’s Mercy. It seemed
logical to Angie and her family that she
would pursue further training in pediatric
oncology; but in her second year of
residency, she became interested in
infectious diseases. She completed a
fellowship in infectious diseases here
at Children’s Mercy and has stayed on
as faculty. Even though she is not the
primary physician for cancer patients,
she appreciates the opportunity to
be able to take care of these patients,
and get to know some of them as a
consultant.
Incidentally, Children’s Mercy is the
place where she met and married her
husband of eight years, who is a private
practice pediatrician. Angie now has 2
children, and has remained cancer-free
for the last 11 years.
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Osteosarcoma – A Multi-disciplinary
Effort of Care

The staff of Children’s Mercy Hospital works hard to ensure that all
patients receive timely, compassionate, and world class care. These
are some of the areas that are important in the care of children with
Osteosarcoma.
Radiology
The Department of Radiology is an important resource in the care of children with
bone tumors. The mission of the members of the radiology team is to provide the
best diagnostic tools available. Their work enables the oncology and surgical teams
to successfully treat these children.
A child with osteosarcoma is usually diagnosed after a plain X-ray of the bone. The
tumor is then further characterized with an MRI which helps to determine the extent
of the tumor and show if there are any additional areas of tumor in that bone. After
osteosarcoma is diagnosed, a bone scan is used to look at the other bones in the
body to evaluate for metastatic disease. A small amount of radiotracer is injected
into the veins and localizes in the very active tumor sites. A chest CT is used to
examine the chest for metastatic disease. Bone scans and CT are also used to
monitor the tumor during therapy.
In the near future, the hospital will be opening a new state-of-the-art MRI center.
This will house new 3 tesla and 1.5 tesla magnets. The scanners will include all
available advanced imaging techniques and software that will improve imaging of
bone, cartilage, and joints.
Surgery
The Orthopaedic Surgery section works hand in hand with oncology colleagues to
diagnose, treat, and follow patients diagnosed with osteogenic sarcoma.
Most children diagnosed with osteogenic sarcoma are active, healthy adolescents.
When a diagnosis is suspected, the sections of Hematology/Oncology and
Orthopaedics work efficiently to arrange for a biopsy, obtain an accurate diagnosis,
and initiate medical management. Effective communication between the sections
ensures prompt tumor resection and reconstruction at the completion of adjuvant
chemotherapy, as well as the safe resumption of adjuvant chemotherapy following
surgical reconstruction.
Upon completion of reconstruction and adjuvant chemotherapy, osteosarcoma
patients continue to be “co-followed” by physicians in each section to maximize
function, and identify recurrent disease.
Pathology
Osteosarcoma is an aggressive cancer and it is important to make the accurate
diagnosis for the sake of the patient’s management. Pathologists are involved in
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making the initial diagnosis as well as gauging the treatment response. When a
tumor is suspected clinically or from radiologic studies, the orthopaedic surgeon
performs a biopsy of the tumor through a needle core. The biopsy specimen is
sent to pathology for histological processing. The pathologist reviews the patient’s
material prepared on a glass slide through a microscope and determines if there
is an osteosarcoma or not. The pathologist then communicates the results to the
surgeon or to the treating oncologist.
Patients with osteosarcoma receive a treatment regimen that includes
chemotherapy and surgical resection of the bone containing the tumor. At the time
of the surgery, the pathologist examines the limb bone and confirms the biopsy
diagnosis. The microscopic appearance of the tumor varies according to biology
of the tumor and whether the tumor cells are predominantly forming bone (i.e.
osteoblastic), cartilage (i.e. chondroblastic), or fibrous tissue (i.e. fibroblastic). Other
rare histologic variants of osteosarcoma that may affect the patient’s prognosis can
also be identified. The pathologist will also determine the degree of tumor extension
in the bone. Microscopic examination of the tumor will also reveal whether the
tumor was successfully treated with chemotherapy or not. The presence of extensive
tumor necrosis (non-viable tumor cells) after chemotherapy is a good sign that the
patient’s treatment was successful.
Cytogenetics
Osteosarcoma is the most common malignant bone tumor in childhood and
adolescence. The cause of osteosarcoma is unknown. However, it is known
that mutations of specific genes can predispose patients to tumors, including
osteosarcoma. While the majority of osteosarcomas are sporadic and not inherited,
two autosomal dominantly inherited disorders predispose to osteosarcoma,
familial retinoblastoma and Li Fraumeni syndrome. A germline mutation of the
RB1 gene at chromosome location 13q14 predisposes patients to retinoblastoma
and osteosarcoma. A germline mutation of the TP53 gene at chromosome
location 17p13 causes Li Fraumeni syndrome which predisposes patients to many
tumors including osteosarcoma. Studying these genes helps to shed light on the
pathogenesis of the tumors with the goal of discovering effective treatment options.
Even in sporadic osteosarcomas, changes in the RB1 gene and TP53 gene are the
most common recurrent abnormalities.
The cytogenetic laboratory processes living tumor tissue removed from the patient
at the time of surgery in order to grow the tumor cells in culture. The cells are
captured as they divide so the chromosomes can be examined. The genes reside on
the chromosomes and by examining the chromosomes, the abnormal genes can be
studied. Most often the chromosomes of an osteosarcoma are very mixed up with
many abnormalities. This makes it difficult to determine which of the many genetic
changes are responsible for the initiation of the tumor and which are responsible
for the aggressive behavior that is characteristic of most osteosarcomas. Studying
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osteosarcoma tumor cells gives an opportunity to identify the genes responsible for
the development and behavior of these tumors. Continued study will undoubtedly
lead to the identification of new treatment agents and possibly gene therapy
Social Work
Social workers are an integral part of the medical team as they demonstrate the
importance we place on comprehensive, family centered care. Our social workers
hold a Master’s degree and each has expertise serving the needs of our children
and their families. Each social worker works closely with a primary oncologist and
advanced practice nurse as the patient and family’s primary team.
At diagnosis, the primary team sits down with the patient’s family and patient (when
age appropriate). As a group, they discuss the diagnosis, treatment plan and begin
to answer questions. The social worker provides supportive counseling and assists
the family in organizing their own resources. They also begin identifying additional
resources that could aid the family in the journey ahead.
The social worker completes a psychosocial assessment on each patient. This forms
the basis for the subsequent relationship with the child and family. The assessment
aids the family and social worker in determining the resources and assistance
needed as well as making preparations to begin treatment.
Social workers provide counseling as patient, parents, and siblings begin to heal
both physically and emotionally from the diagnosis. In addition, when appropriate,
they make referrals to other psychosocial team members such as child life,
chaplaincy, and child psychology.
For school-aged children, social workers assist parents and the school to ensure
that the child’s educational needs are being met. Social workers may attend IEP
(Individual Education Plan) meetings with parents to assist with developing a plan
that the patient and accomplish both during and after treatment. Social workers
also provide supportive counseling to the patient and fellow students as the patient
returns to school.
Social workers refer patients and their families to outside agencies for support,
education, and financial assistance. Families get assistance from such groups as
The American Cancer Society, National Children’s Cancer Society, Turning Point and
Solace House. Referrals for lodging and transportation assistance are also given
with appropriate.
To provide support specifically to parents, the Hematology/Oncology Division at
Children’s Mercy Hospital offers the Parent to Parent program, coordinated by a
social worker. Experienced parents of children with cancer volunteer and are paired
with a family of a child newly diagnosed. The volunteer shares their expertise and
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offers support. The program also offers bereavement services to families. This
service is also staffed by parent volunteers who have lost a child to cancer.
In addition to the Parent to Parent support, social workers also offer counseling and
support to families who are grieving the loss of a child. Families are guided through
the funeral process and continue to receive support once outside the hospital. Both
internal bereavement groups and outside resources are offered in order to best
meet the needs of each individual family.
Social workers realize that treatment is not merely a series of medications, clinic
appointments, and inpatient hospitalizations. It is a process where the most
important outcome is that the patient and family are able to define their “new
normal” after treatment ends.
For many of our patients with osteosarcoma, their lives will never be the same. They
will require adjustment, assistance, equipment and opportunities to discover what
their new normal looks like. As part of an ongoing partnership with each patient and
family, social workers consider it their privilege to accompany patients and families
on their journey and bear witness to their determination, courage and resilience.
Nutrition
Osteosarcoma presents unique nutrition challenges compared with other pediatric
malignancies. This is due to the severe irritation of the gastrointestinal (GI)
tract associated with chemotherapy. Chemotherapy for Osteosarcoma results in
severe nausea and vomiting, often difficult to control with medications, as well as
inflammation and sloughing of the tissues lining the GI tract. This irritation leads
to painful sores in the mouth and throat, and often the entire length of the GI tract
(stomach, intestines, colon, and anus). The combination of side effects makes
eating extremely difficult, and medication or hospitalization for pain control are
necessary. The majority of children and teens with Osteosarcoma also require
medications to increase their appetite, in addition to a diet high in calories, protein
and antioxidant vitamins from fruits and vegetables to help repair the tissue damage
associated with chemotherapy. Commonly kids and teens struggle to maintain their
weight and muscle strength, and eventually require supplemental medical nutrition
from a temporary tube feeding or intravenous infusion of nutrients. A feeding tube
inserted into the stomach (into the nose and down the throat) can help repair
damaged tissue, but may not be placed in the presence of significant inflammation
or sores. For those children and teens, specialized intravenous solutions of calories,
protein, fat, vitamins and minerals are often required.
The medical team relies on the patient and family’s assessment of their daily level
of functioning and tolerance to therapy to guide the nutrition care plan. Laboratory
tests of the blood and measurements of the body are routinely monitored by a
registered dietitian specializing in nutrition support along with the medical team
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for continual nutrition assessment during therapy. Growth parameters are also
monitored long-term by the medical team to screen for late-effects of chemotherapy
on development
Behavioral Medicine
The Section of Developmental and Behavioral Sciences offers comprehensive
psychological services to children and families affected by osteosarcoma, as well as
other forms of cancer. Services are tailored to the needs of each child and family.
Staff members provide a listening ear, as well as facilitate coping with the stressors
that accompany the diagnosis and treatment. Counseling can be done both on the
inpatient unit, and in the Developmental and Behavioral Sciences Clinic. Individual
or family services can be offered to the patient, siblings and parents. This is part
of the commitment to provide family centered care throughout CMH. In addition
to a designated psychologist who works closely with the Division of Hematology/
Oncology, consultative services with a psychiatrist and family therapist are also
available.
Children tend to be quite resilient, and their ability to cope with life’s most difficult
challenges can amaze the adults around them. However, when facing cancer
diagnosis and treatment, children benefit from having additional support to help
them adjust to what is happening to them. Children with osteosarcoma may have
to face surgeries that alter the appearance and/or functioning of their bodies,
including amputation. Psychological support can help address the body image
issues that accompany such changes, and that sometimes can lead to symptoms of
depression, anxiety, etc. These children also face challenges in reintegrating back
into their school settings, and the psychologist works with the interdisciplinary team
to help the children make this transition in a healthy way.
Rehabilitation Medicine
Kids with osteosarcoma may have a hard time functioning as they should for
their age, depending upon the site of the tumor and the course of treatment.
Some children need surgeries to keep their limb as functional as it can be, and
others need amputation either as treatment, or in order to allow them to be more
functional, along with prosthetic (artificial limb) fitting. The goal of Rehabilitation
involvement is to help return the child to an active, positive and functional lifestyle,
and this team joins the oncology team and other health care providers whenever
their expertise is needed.
The Rehabilitation Team includes a diverse group of caregivers with pediatric
rehabilitation physicians, physical therapists, occupational therapists, speech
therapists, recreational therapists, rehabilitation nurses, a neuropsychologist,
social workers, dieticians, orthotists and prosthetists, respiratory therapists, music
therapist, and child life specialists. This team of experts focuses on function for
children who lose skills due to illness or injury. For each child this team works to
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identify what skills and activities are more challenging, and design a plan to improve
those skills. This takes a combination of hands-on therapy, assistive devices such
as a brace or walker, restorative devices such as a brace or prosthesis for an arm or
leg, and training in the skills needed that the child and his or her family can work on.
This may take place in the hospital or after discharge, on an out-patient basis.
The Rehabilitation Team may get involved with children who have osteosarcoma at
a number of different points in their treatment. With medical treatment and longer
hospital stays, a child may have weakness that gets better with therapy, and play-like
activities that help with strengthening. After a limb salvage surgery, it is important
to start moving the knee or the affected body part almost immediately. For example,
a continuous passive motion (CPM) machine may be used to improve motion
after limb-salvage surgery for tumors around the knee by constantly bending and
straightening the leg. It works by continuously bending and straightening the knee.
Physical therapy helps the child learn to walk again, first with a walker or crutches
and then later, without any assistive devices. This process may take six to 12 months
following surgery.
Amputation or removal of all or part of a limb may be necessary as part of
treatment. In some children with osteosarcoma of the leg, amputation provides a
better chance than limb-salvage of returning a child to an active lifestyle, including
play, running and sports. Our Limb Deficiency Team includes a rehabilitation doctor,
an orthopaedic surgeon, physical and occupational therapy, rehabilitation nurses,
and prosthetists. (A prosthetist is a professional who makes artificial limbs.) The
team works in a clinic which is part of an international group of professionals
dedicated to the care of children with amputations, known as ACPOC, or the
Association of Children’s Prosthetic Orthotic Clinics, and through that association
we provide children with amputation, their families, their doctors and other care
providers with information about amputation and prosthetic intervention. This team
may get involved even before a planned amputation to help decide what level of limb
removal will allow the best options for prosthetic fitting and overall function. They
also can link children to other children with similar issues, which helps with coping
and hope.
Depending on the level of the amputation and other medical factors, a new artificial
leg can be fitted right away after surgery. But often a period of healing and limb
preparation is needed before fitting. It usually takes at least three to six months until
a young person learns to use a prosthetic (artificial) leg or arm well, and this is just
the beginning of long-term physical and psychological rehabilitation. The team then
has the child return twice a year to make sure the prosthesis fits, and best suits the
needs of the child.
Rehabilitation efforts are tailored to the unique needs of each child with
Osteosarcoma.
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Tyler Bartlett
Tyler’s Triumph

The following is a letter from Tyler’s mother:

Subject: T
yler and basketball
11-28-07 Last night was the best night in a long time and the worst night in
a long time. We got a call Monday night that the cubs would need to be at
the McEowen school on Tuesday night to help with the Hoops for Hearts. It
is a fundraising for something and the cubs were to be there at 6 pm. We
showed up and the kids had taken up pledges to make so much for each
basket they made. The third graders went and then fourth graders were
going. T
yler said he wanted to go.
Now picture this. They started two kids in center of basketball court.
Each kid had to run to one end and make a basket from squares set on
floor. They had 30 seconds to make as many baskets as they could. Then
they got to do it again. They largest amount of baskets was the number
they could use to get pledges.
T
yler kept asking me if he could play. I said no that they were doing too
much too fast. He kept begging and I finally gave in. I was scared that
he would fall while running, not make any baskets and be depressed and
had many other thoughts running thru my mind. He walked over to the side
of the gym that other kids were sitting at and sat down. The coach
went over and talked to him.
Then he called T
yler’s name and another girl’s name and she came out.
She also had leukemia a few years ago. The coach let T
yler go closer to basket and then set off the
timer. He made 2 baskets during the first set. Then he made a basket during the second set.
There was an older girl who came in and finally helped him run after the ball. All the kids were yelling “Go
T
yler Go” and the parents were yelling. He finished and went to sit down. Then he came over and sat on my
lap and said he was ready to go home. We left he was so excited that he had been able to play. He likes
basketball so much. So like I said it was the best of times and the worst of times. He was happy and I
was worried. But I was so PROUD of him. He is really trying to be as normal (as normal as possible) as
he can be. I really am thankful for friends. I don’t know what I would do without them. My love goes out
to all of you.
God bless.
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